Literature DB >> 2394351

Mannan and oligomers of N-acetylglucosamine protect intestinal mucosa of celiac patients with active disease from in vitro toxicity of gliadin peptides.

S Auricchio1, G De Ritis, M De Vincenzi, G Magazzù, L Maiuri, E Mancini, M Minetti, O Sapora, V Silano.   

Abstract

Wheat flour and other cereals toxic for celiac patients contain an alcohol-soluble protein fraction that, under experimental conditions simulating in vivo protein digestion, yields peptides that agglutinate undifferentiated K 562(S) cells. In contrast, cereals well tolerated in celiac disease (i.e., rice and maize) do not. Furthermore, purified A-gliadin peptides that damage in vitro-cultured flat celiac mucosa are powerful agglutinins for K 562(S) cells, whereas A-gliadin peptides that do not show any adverse in vitro effect on celiac intestine lack agglutinating activity. Mannan, acetylglucosamine, and its oligomers (N,N'-diacetylchitobiose and N,N',N"-triacetylchitotriose) were able to prevent and reverse cell agglutination induced by peptides from all the toxic cereals. Moreover, mannan and N,N',N"-triacetylchitotriose exhibited a protective effect on intestinal mucosa specimens of patients with active celiac disease cultured with wheat protein-derived peptides. These data are consistent with the hypothesis that the agglutinating and toxic peptides are bound by carbohydrates.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2394351     DOI: 10.1016/0016-5085(90)90615-8

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  8 in total

1.  Agglutinating activity of alcohol-soluble proteins from quinoa seed flour in celiac disease.

Authors:  M De Vincenzi; M Silano; R Luchetti; B Carratù; C Boniglia; N E Pogna
Journal:  Plant Foods Hum Nutr       Date:  1999       Impact factor: 3.921

2.  Sourdough bread made from wheat and nontoxic flours and started with selected lactobacilli is tolerated in celiac sprue patients.

Authors:  Raffaella Di Cagno; Maria De Angelis; Salvatore Auricchio; Luigi Greco; Charmaine Clarke; Massimo De Vincenzi; Claudio Giovannini; Massimo D'Archivio; Francesca Landolfo; Giampaolo Parrilli; Fabio Minervini; Elke Arendt; Marco Gobbetti
Journal:  Appl Environ Microbiol       Date:  2004-02       Impact factor: 4.792

3.  Binding of gliadin to lymphoblastoid, myeloid and epithelial cell lines.

Authors:  M A Farré Castany; P Kocna; H Tlaskalová-Hogenová
Journal:  Folia Microbiol (Praha)       Date:  1995       Impact factor: 2.099

4.  Proteolysis by sourdough lactic acid bacteria: effects on wheat flour protein fractions and gliadin peptides involved in human cereal intolerance.

Authors:  Raffaella Di Cagno; Maria De Angelis; Paola Lavermicocca; Massimo De Vincenzi; Claudio Giovannini; Michele Faccia; Marco Gobbetti
Journal:  Appl Environ Microbiol       Date:  2002-02       Impact factor: 4.792

5.  The role of NF-kappaB, IRF-1, and STAT-1alpha transcription factors in the iNOS gene induction by gliadin and IFN-gamma in RAW 264.7 macrophages.

Authors:  Daniela De Stefano; Maria Chiara Maiuri; Barbara Iovine; Armando Ialenti; Maria Assunta Bevilacqua; Rosa Carnuccio
Journal:  J Mol Med (Berl)       Date:  2005-11-12       Impact factor: 4.599

6.  Gliadin increases iNOS gene expression in interferon-gamma-stimulated RAW 264.7 cells through a mechanism involving NF-kappa B.

Authors:  Maria Chiara Maiuri; Daniela De Stefano; Guido Mele; Barbara Iovine; Maria Assunta Bevilacqua; Luigi Greco; Salvatore Auricchio; Rosa Carnuccio
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-07-04       Impact factor: 3.000

7.  FAS engagement drives apoptosis of enterocytes of coeliac patients.

Authors:  L Maiuri; C Ciacci; V Raia; L Vacca; I Ricciardelli; F Raimondi; S Auricchio; S Quaratino; M Londei
Journal:  Gut       Date:  2001-03       Impact factor: 23.059

8.  Antinociceptive and anti-inflammatory activity of α-d-mannan from Pseudozyma sp.

Authors:  Gildomar Lima Valasques Junior; Jener David Gonçalves Dos Santos; Pedro Felipe Pereira Chaves; Lucimara Mach Côrtes Cordeiro; Cleisiane Lima de Jesus; Flávia Oliveira de Lima; Elisangela Fabiana Boffo; Sandra Aparecida de Assis
Journal:  3 Biotech       Date:  2021-01-13       Impact factor: 2.406

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.